Journals / Interdisciplinary Medical Journal / 2026 / Volume: 17 Issue: 58

The role and importance of pericardial effusions in the diagnosis of malignancy

Tülay Koç(CUMHURİYET ÜNİVERSİTESİ)0000-0001-8612-0238
Nisa Begüm Öztürk(SİVAS CUMHURİYET ÜNİVERSİTESİ)0000-0001-8614-271X
Ersin Tuncer(SİVAS CUMHURİYET ÜNİVERSİTESİ)0000-0002-7150-8835
Anıl Şahin(CANAKKALE ONSEKIZ MART UNIVERSITY)0000-0003-1956-2348
Pages
—
Publication Date
2026-08-23
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Despite the study’s limited sample size, the findings underscore the importance of cytological evaluation in guiding the diagnosis and management of pericardial effusions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Pericardial effusion is a clinical condition characterized by the pathological accumulation of fluid within the pericardial cavity.
📊
Key Findings & Data:Malignancy-related effusions, particularly in patients with advanced-stage cancer, may cause significant morbidity and mortality.
💡
Conclusion & Impact:Despite the study’s limited sample size, the findings underscore the importance of cytological evaluation in guiding the diagnosis and management of pericardial effusions.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Pericardial Effusion · Cytology · Malignancy

Abstract

Objective: Pericardial effusion is a clinical condition characterized by the pathological accumulation of fluid within the pericardial cavity. It may develop secondary to cardiac, infectious, autoimmune, traumatic, or neoplastic processes. Malignancy-related effusions, particularly in patients with advanced-stage cancer, may cause significant morbidity and mortality. Cytological examination of pericardial fluid is an effective and minimally invasive diagnostic method for differentiating malignant from benign etiologies. In this study, it was aimed to retrospectively evaluate the cytological findings of pericardial effusion samples obtained by pericardiocentesis and to determine the malignancy rate. Method: This retrospective study included 26 patients who underwent pericardiocentesis at the Cardiology Clinic of Sivas Cumhuriyet University between January 2019 and September 2022. Cytological smears were stained with Papanicolaou and Giemsa methods. The cases were categorized as benign/reactive, malignant, suspicious for malignancy, or non-diagnostic. When necessary, cell blocks were prepared, and immunohistochemical analyses using markers such as TTF-1 and GATA-3 were performed. Results: The mean age of the patients was 58.5 years; 17 (65.4%) were female and 9 (34.6%) were male. Cytological evaluation revealed 13 (50%) benign/reactive, 6 (23%) malignant, 6 (23%) suspicious for malignancy, and 1 (4%) non-diagnostic cases. All malignant effusions were metastatic in origin, most frequently lung adenocarcinoma, followed by breast carcinoma and lymphoma. Conclusion: Pericardial fluid cytology is an effective method for detecting malignancy in patients with pericardial effusion. Cell block and immunohistochemical analyses improved diagnostic accuracy. Despite the study’s limited sample size, the findings underscore the importance of cytological evaluation in guiding the diagnosis and management of pericardial effusions.

🔖

Cite This Article

Koç, T., Öztürk, N. B., Tuncer, E., Şahin, A. (2026). The role and importance of pericardial effusions in the diagnosis of malignancy. Interdisciplinary Medical Journal, Volume: 17 Issue: 58. https://doi.org/10.17944/interdiscip.1820578

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Shartouni R, Shartouni R, Mahmoodi M, Nikas IP. The Value of Cytology in the Evaluation of Malignant Pericardial Effusions: A Systematic Review. Diagnostics (Basel). 2022;12(2):367. https://doi.org/10.3390/diagnostics12020367
  2. Khandaker MH, Espinosa RE, Nishimura RA, Sinak LJ, Hayes SN, Melduni RM, et al. Pericardial disease: Diagnosis and management. Mayo Clin Proc. 2010;85(6):572–93. https://doi.org/10.4065/mcp.2010.0046
  3. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36(42):2921–64. https://doi.org/10.1093/eurheartj/ehv318
  4. Mori S, Bertamino M, Guerisoli L, Stratoti S, Canale C, Spallarossa P, et al. Pericardial effusion in oncological patients: current knowledge and principles of management. Cardiooncology. 2024;10(1):8. https://doi.org/10.1186/s40959-024-00207-3
  5. Wang S, Zhao J, Wang C, Zhang N. Prognosis and role of clinical and imaging features in patients with malignant pericardial effusion: a single-center study in China. BMC Cardiovasc Disord. 2021;21(1):1–6. https://doi.org/10.1186/s12872-021-02331-9
  6. Mudra SE, Rayes D, Kumar AK, Li JZ, Njus M, McGowan K, et al. Malignant Pericardial Effusion: A Systematic Review. CJC Open. 2024;6(8):967–72. https://doi.org/10.1016/j.cjco.2024.05.003
  7. Yadav S, Singh M, Singh P, Mandal S, Khurana N, Jain S. Cytological evaluation of pericardial fluids: A 5 years experience in tertiary care center. Indian J Pathol Microbiol. 2019;62(2):270–3. https://doi.org/10.4103/ijpm.ijpm_360_18
  8. Aksoy Altinboğa A, Kivrak N. Cytopathological evaluation of pericardial effusions: 192 cases in a tertiary-level healthcare centre. Turk J Med Sci. 2025;55(2):423–31. https://doi.org/10.55730/1300-0144.5986
  9. Pinto D, Chandra A, Crothers BA, Kurtycz DFI, Schmitt F. The International System for Reporting Serous Fluid Cytopathology—Diagnostic Categories and Clinical Management. J Am Soc Cytopathol. 2020;9(6):469–77. https://doi.org/10.1016/j.jasc.2020.07.091
  10. Yildirim M, Ustaalioglu R, Erkan M, Ustaalioglu BBO, Demirbag H, Yasaroglu M, et al. The Diagnostic Value of Pericardial Fluid and Pericardial Biopsy: Single Center Experiences. Heart Surg Forum. 2016;19(1):E23–7. https://doi.org/10.1532/hsf.1328
  11. Burazor I, Imazio M, Markel G, Adler Y. Malignant Pericardial Effusion. Cardiology. 2013;124(4):224–32. https://doi.org/10.1159/000348559
  12. Sundling KE, Cibas ES. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology. Cancer Cytopathol. 2018;126 Suppl 8:590–8. https://doi.org/10.1002/cncy.22021
  13. Kalogeraki A, Lazopoulos G, Papadakis GZ, Tamiolakis D, Karvela-Kalogeraki I, Karvelas-Kalogerakis M, et al. Cytology of Pericardial Effusion due to Malignancy. Rom J Intern Med. 2016;54(3):179–83. https://doi.org/10.1515/rjim-2016-0026
  14. Sezenöz B, Göçün FPU, Kızıltunç E, Topal S, Özdemir HM. The prognostic impact of pericardial fluid cytology in malignant pericardial effusion. Anatol J Cardiol. 2023;27(1):41-6. https://doi.org/10.14744/AnatolJCardiol.2022.2050
  15. Strobbe A, Adriaenssens T, Bennett J, Dubois C, Desmet W, McCutcheon K, Sinnaeve PR. Etiology and long-term outcome of patients undergoing pericardiocentesis. J Am Heart Assoc. 2017;6(12):e007598. https://doi.org/10.1161/JAHA.117.007598
  16. Mandal A, Ayub A, Mukherjee M, Sinha RK, Kumar N, Lakra PS, et al. Diagnosis of Body Fluids Using a Combined Approach of Cytomorphology in Routinely Stained Smears and Cell Blocks: A Boon for Primary Health Care in this Era of Molecular Medicine. J Public Health Prim Care. 2024;5(2):61–7. https://doi.org/10.4103/jphpc.jphpc_51_23